Compare Humana Inc (HUM) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Microsoft — how do they compare? Humana Inc trades at $378.03 (market cap $46.31B), while Microsoft trades at $502.24 (market cap $3.76T). The key difference: Microsoft is far larger — about 81.2× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | MSFT | |
|---|---|---|
Market Cap | $46.31B | $3.76T |
Sector | Health | Technology |
52-Week High | $409.42 | $542.07 |
52-Week Low | $163.67 | $352.83 |
Enterprise Value | $53.67B | $3.74T |
Dividend Yield | 0.92% | 0.72% |
Volume | — | 36,654,621 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Microsoft (MSFT) trades at $501.28, up 0.26% on the day, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $4.74 exceeding the $4.24 forecast. Revenue growth is robust, reaching $281.72 billion in 2025, with a net income margin of 40.31%. Analyst sentiment is overwhelmingly positive, with 80.49% recommending Buy and a consensus price target of $553.70.
The outlook for MSFT remains favorable, driven by AI leadership, Azure cloud momentum, and solid financials. Key risks include elevated capital expenditure concerns and competitive pressures. With a P/E of 28.19, the valuation is premium but supported by growth. Institutional ownership trends and recent dividend actions underscore confidence, though investors should monitor execution on AI investments and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
